Drug Research
China Remains An Attractive Market For Pharma Investment
A collection of notable recent developments in the Chinese pharmaceutical industry indicates that despite ongoing political tensions, multinational pharmaceutical companies still find China an...
Drug Research
Promising Future For The Global CRO Market With 8.4% CAGR
As per insights, the global clinical research organization (CRO) market is projected to achieve a value of $139.56 billion by 2033. The market is...
News
Germany – Saudi Arabia Tie – Up To Boost Rare Disease Testing
Centogene, a life science company based in Germany that specializes in rare and neurodegenerative diseases, and Lifera, a biopharmaceutical company owned by the Public...
News
From Decline To Rebound: Biotech M&A Expected To Bounce Back
2022 was an unremarkable year for biotech mergers and acquisitions (M&A) as the industry experienced a decline in both the number and value of...
News
Ardena and RiboPro Forge Strategic Alliance to Support the RNA Revolution with End-to-End Manufacturing of Advanced mRNA and LNP Solutions
Leading contract development manufacturer of nanomedicines, Ardena, has joined forces with mRNA and LNP technology specialists RiboPro to form a new strategic commercial alliance aimed at delivering...
News
Pharma Targeting Launch Partner Identifier to Intelligently Connect the Dots between Data and Business Opportunity for Pharma Clients
Pharma Targeting, part of the The Targeting Group and a leading global pharmaceutical market intelligence and data company, has unveiled its latest pioneering initiative,...
News
Pharmaceutical Products Take Center Stage In US – China Trade
The US-China trade in pharmaceuticals has shifted due to the trade war and the pandemic. While some sectors have seen a decline, pharmaceutical trade...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from up to 5 devices at once
Must read